So, is the new "Rapid DNA test/s ...not yet approved by the FDA"
a competition to CST or a complimentary in diagnosis.
I am not clear the way it is written if it is a *TB diagnostic*
e.g.. "...by cutting delays in diagnosis of drug-resistant tuberculosis"
or a *drug resistance detector* for isoniazid and rifampin?
e.g.. "which detects resistance to isoniazid and rifampin."
Can someone clarify?
Add to My Watchlist
What is My Watchlist?
